Log in

NASDAQ:MTBCMTBC Stock Price, Forecast & News

-0.61 (-5.10 %)
(As of 08/14/2020 04:00 PM ET)
Today's Range
Now: $11.35
50-Day Range
MA: $10.45
52-Week Range
Now: $11.35
Volume138,362 shs
Average Volume176,632 shs
Market Capitalization$140.74 million
P/E RatioN/A
Dividend YieldN/A
MTBC, Inc., a healthcare information technology (IT) company, provides an integrated suite of Web-based solutions and related business services to healthcare providers primarily in the United States. The company operates through two segments, Healthcare IT and Practice Management. It primarily offers PracticePro, a software-as-a-service platform, which includes practice management software and related tools that facilitate the day-to-day business operation and workflows; electronic health record (EHR), which enables customers to reduce paperwork; revenue cycle management services, such as end-to-end medical billing, analytics, and related services; and mobile health solutions, including smartphone applications that assist patients and healthcare providers in the provision of healthcare services. The company also provides a web-based EHR solution; healthcare claims clearinghouse services; transcription, coding, indexing, and other ancillary services; electronic data interchange services; talkEHR, a voice enabled EHR solution; business intelligence, customized applications, interfaces, and various other technology solutions; comprehensive practice management services; telemedicine services; and patient experience management solutions. It serves physicians, nurses, nurse practitioners, physician assistants, and other clinical staff that render bills for their services. The company was formerly known as Medical Transcription Billing, Corp. and changed its name to MTBC, Inc. in February 2019. MTBC, Inc. was founded in 1999 and is headquartered in Somerset, New Jersey.
Read More
MTBC logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.35 out of 5 stars

Industry, Sector and Symbol

Industry Prepackaged software
Current SymbolNASDAQ:MTBC



Sales & Book Value

Annual Sales$64.44 million
Cash Flow$0.32 per share
Book Value$3.51 per share


Net Income$-870,000.00


Market Cap$140.74 million
Next Earnings Date11/4/2020 (Estimated)
OptionableNot Optionable
-0.61 (-5.10 %)
(As of 08/14/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MTBC News and Ratings via Email

Sign-up to receive the latest news and ratings for MTBC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

MTBC (NASDAQ:MTBC) Frequently Asked Questions

How has MTBC's stock price been impacted by COVID-19 (Coronavirus)?

MTBC's stock was trading at $5.31 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, MTBC stock has increased by 113.7% and is now trading at $11.35.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of MTBC?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MTBC in the last year. There are currently 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for MTBC

When is MTBC's next earnings date?

MTBC is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for MTBC

How were MTBC's earnings last quarter?

MTBC, Inc (NASDAQ:MTBC) announced its earnings results on Thursday, August, 13th. The technology company reported ($0.65) earnings per share for the quarter, beating analysts' consensus estimates of ($0.69) by $0.04. MTBC had a negative net margin of 6.41% and a negative return on equity of 10.63%.
View MTBC's earnings history

What guidance has MTBC issued on next quarter's earnings?

MTBC issued an update on its FY 2020 Pre-Market earnings guidance on Thursday, August, 13th. The company provided EPS guidance of for the period. The company issued revenue guidance of $105-107 million, compared to the consensus revenue estimate of $105.77 million.

What price target have analysts set for MTBC?

8 brokerages have issued 12-month target prices for MTBC's stock. Their forecasts range from $7.50 to $15.50. On average, they expect MTBC's stock price to reach $11.50 in the next year. This suggests a possible upside of 1.3% from the stock's current price.
View analysts' price targets for MTBC

What are Wall Street analysts saying about MTBC stock?

Here are some recent quotes from research analysts about MTBC stock:
  • 1. March quarter report yesterday validates CareCloud integrationabove and beyond our expectations, but.... MTBC reported 1Q20sales of $21.9M, up 45% from 1Q19's $15.1M on an apples-to-orangesbasis in light of the January 8 closing of CareCloud and the expectedincremental $30-31M in additive sales contribution this year. Further andinterestingly, MTBC has launched its formal "MTBC Force" initiative, amercenary approach to providing services to companies that have greatcustomer interface, but are perhaps weaker on the cost efficiency sideof service and support infrastructure. With three such deals under theirbelt, MTBC management appeared calm, cool, and not exceedinglyambitious in again delivering its $100-102M in sales guidance for 2020yesterday" (5/15/2020)
  • 2. We reiterate our Buy rating on MTBC following Q1 results that beat expectations acrossrevenue, EBITDA and EPS. Q1 was the first quarter in which the CareCloud acquisitioncontributed, and registered a small top-line beat relative to our expectations. Owingto COVID and the precipitous decline in physician visits entering Q2, MTBC expectsQ2 to be down sequentially, with negative EBITDA and EPS. This is not a surprise asfully 60% of MTBC revenue is dependent on physician volumes and charges. Still, MTBCreiterated its full-year view of $100M to $102M in revenue and $12-$13M EBITDA asit has multiple paths to get there, namely its growing Force partner program, and verylikely an acquisition of a tuck-in nature. Depending on the size of the deal, we thinkMTBC could exceed guidance, but for now we have not built any acquired growth in ourmodel and remain slightly below management’s outlook." (5/15/2020)

Has MTBC been receiving favorable news coverage?

News headlines about MTBC stock have trended neutral recently, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. MTBC earned a daily sentiment score of 0.2 on InfoTrie's scale. They also assigned media headlines about the technology company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future.
View the latest news about MTBC

Are investors shorting MTBC?

MTBC saw a drop in short interest during the month of February. As of February 15th, there was short interest totaling 32,300 shares, a drop of 12.2% from the January 31st total of 36,800 shares. Based on an average daily volume of 97,900 shares, the days-to-cover ratio is currently 0.3 days. Approximately 0.5% of the shares of the stock are short sold.
View MTBC's Short Interest

Who are some of MTBC's key competitors?

What other stocks do shareholders of MTBC own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MTBC investors own include NVIDIA (NVDA), Inseego (INSG), Marvell Technology Group (MRVL), Alibaba Group (BABA), Square (SQ), Chesapeake Energy (CHKAQ), Chesapeake Energy (CHKAQ), InVitae (NVTA), IMPINJ (PI) and Aptiv (APTV).

What is MTBC's stock symbol?

MTBC trades on the NASDAQ under the ticker symbol "MTBC."

Who are MTBC's major shareholders?

MTBC's stock is owned by many different institutional and retail investors. Top institutional investors include Cadence Capital Management LLC (2.09%), Bank of Montreal Can (0.64%), Hancock Whitney Corp (0.13%), UBS Group AG (0.12%), Bailard Inc. (0.12%) and Virtu Financial LLC (0.09%). Company insiders that own MTBC stock include A Hadi Chaudhry, Bill Korn, Cameron Munter, John N Daly, Kimberly J Grant, Mahmud Ul Haq, Shruti H Patel and Stephen Andrew Snyder.
View institutional ownership trends for MTBC

Which institutional investors are selling MTBC stock?

MTBC stock was sold by a variety of institutional investors in the last quarter, including Hancock Whitney Corp. Company insiders that have sold MTBC company stock in the last year include A Hadi Chaudhry, Bill Korn, Cameron Munter, John N Daly, Kimberly J Grant, Mahmud Ul Haq, and Shruti H Patel.
View insider buying and selling activity for MTBC

Which institutional investors are buying MTBC stock?

MTBC stock was bought by a variety of institutional investors in the last quarter, including Bailard Inc., Virtu Financial LLC, Cadence Capital Management LLC, UBS Group AG, Advisor Group Holdings Inc., and Bank of Montreal Can.
View insider buying and selling activity for MTBC

How do I buy shares of MTBC?

Shares of MTBC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is MTBC's stock price today?

One share of MTBC stock can currently be purchased for approximately $11.35.

How big of a company is MTBC?

MTBC has a market capitalization of $140.74 million and generates $64.44 million in revenue each year. The technology company earns $-870,000.00 in net income (profit) each year or ($0.60) on an earnings per share basis. MTBC employs 2,700 workers across the globe.

What is MTBC's official website?

The official website for MTBC is www.mtbc.com.

How can I contact MTBC?

MTBC's mailing address is 7 CLYDE ROAD, SOMERSET NJ, 08873. The technology company can be reached via phone at 732-873-5133.

This page was last updated on 8/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.